The firm is a Europe-based venture capital investor specializing exclusively in medical technology. The firm typically invests €5M–€15M per company and manages dedicated investment funds focused on innovative medical devices and related technologies. The firm takes an active investment approach and can lead financing rounds or participate alongside other specialist investors. The firm primarily targets investment opportunities across Europe, Israel, and North America.
The firm focuses on medical technologies addressing significant cardiovascular, neurovascular, and other chronic disease indications. Areas of particular interest include structural heart disease, heart failure, aortic and peripheral vascular disease, stroke, hypertension, and electrophysiology. The firm also selectively evaluates neuromodulation, medical robotics, medical imaging, and patient monitoring technologies, particularly those with applications in cardiovascular and neurovascular care. The firm primarily invests in clinical-stage through commercial-stage medical technologies and does not target pharmaceuticals, biotechnology, healthcare services, or wellness products.
From a company and management team perspective, the firm seeks experienced medical technology entrepreneurs developing differentiated products that address significant unmet clinical needs. The firm takes an active role in supporting portfolio companies across clinical development, regulatory strategy, reimbursement, commercialization, financing, and international market expansion. The firm leverages relationships with physicians, hospitals, clinical research institutions, and industry experts to support product development and market access. The firm generally seeks active governance involvement following investment.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
